Advancing Equitable & Sustainable Healthcare
Bayer is committed to ensuring all patients have access to the clinically appropriate treatment and care they need. We have developed a number of resources to help you to identify your priorities and support you in your decision making so that we reduce variation, health inequalities and optimise treatment in the NHS.
Listen to an expert panel give an overview and bring to life the importance of population health management in improving health outcomes for individuals and communities, and how it can be leveraged to address healthcare disparities.
This webinar was initiated and fully funded by Bayer for PM Healthcare.
Watch Patrick McGinley give a 15-minute introduction to PLICS including providing you with an insight into how it can be used and how it can help inform your decision making.
Duration - 15 minutes
Tackling CVD, including prevention, early detection and treatment remains a key national priority outlined in the NHS Long Term Plan.[1] CKD is recognised as a major risk factor for the development of CVD.[2] Currently there is significant unmet need across the detection and management of these conditions. Access the resources below to better understand why CVD and CKD should be prioritised and how Bayer can support the NHS to address the burden of these diseases.
Abbreviations
CKD - Chronic Kidney Disease
CVD - Cardiovascular Disease
PP-MACS-GB-0165 | August 2024